Proceedings of the 5th Meeting of Translational Hepatology, organized by the Spanish Association for the Study of the Liver (AEEH)

Identificador:  imarina:9411330

Handle: https://hdl.handle.net/20.500.11797/imarina9411330

Autores:  Alvarado-Tapias, E; Maya-Miles, D; Albillos, A; Aller, R; Ampuero, J; Andrade, RJ; Arechederra, M; Aspichueta, P; Banales, JM; Blas-Garcia, A; Caparros, E; Delgado, TC; Carrillo-Vico, A; Claria, J; Cubero, FJ; Diaz-Ruiz, A; Fernandez-Barrena, MG; Fernandez-Iglesias, A; Fernandez-Veledo, S; Frances, R; Gallego-Durán, R; Gracia-Sancho, J; Irimia, M; Lens, S; Martinez-Chantar, ML; Minguez, B; Munoz-Hernandez, R; Nogueiras, R; Ramos-Molina, B; Riveiro-Barciela, M; Rodriguez-Peralvarez, ML; Romero-Gómez, M; Sabio, G; Sancho-Bru, P; Ventura-Cots, M; Vidal, S; Gahete, MD

Resumen:
This is the summary report of the 5th Translational Hepatology Meeting, endorsed by the Spanish Association for the Study of the Liver (AEEH) and held in Seville, Spain, in October 2023. The meeting aimed to provide an update on the latest advances in the field of basic and translational hepatology, covering different molecular, cellular, and pathophysiological aspects of the most relevant clinical challenges in liver pathologies. This includes the identification of novel biomarkers and diagnostic tools, the understanding of the relevance of immune response and inflammation in liver diseases, the characterization of current medical approaches to reverse liver diseases, the incorporation of novel molecular insights through omics techniques, or the characterization of the impact of toxic and metabolic insults, as well as other organ crosstalk, in liver pathophysiology. (c) 2024 The Author(s). Published by Elsevier Espana, S.L.U. This is an open access article under the CC BY-NC license (http://creativecommons.org/licenses/by-nc/4.0/).